Stock Analiz

BDX vs RMD stock comparison

Becton Dickinson & vs. Resmed · data as of November 13, 2026

Becton Dickinson & (BDX) has a market value of about $59.4B, Resmed (RMD) about $33.7B. Over their latest twelve months Becton Dickinson & had revenue of $19.5B and Resmed $5.7B.

On our five checks Resmed scores higher: 4.2 out of 5 (excellent) against 2.0 (weak).

By area, the stronger company is Resmed on value; Resmed on future growth; Resmed on track record; Resmed on financial health.

Resmed is cheaper on earnings (P/E 21.8 vs. 43.1).

Becton Dickinson & leads on 6 of the compared lines and Resmed on 18.

Side by side

BDXRMD
Size and price
Market cap$59.4B$33.7B
Share price$218.03$239.53
Score
Overall score (of 5)2.04.2
Value03
Future growth24
Track record25
Financial health25
Shareholder returns44
Valuation
P/E (TTM)43.121.8
Forward P/E17.518.9
Price / free cash flow22.020.9
Price / sales3.15.9
EV / EBITDA14.315.9
PEG2.610.83
DCF value vs. price−41%−28%
Business
Revenue$19.5B$5.7B
Net income$1.1B$1.6B
Free cash flow$2.7B$1.6B
Net margin5.9%27.8%
Gross margin (5-yr avg.)44.6%57.9%
ROIC (5-yr avg.)4.8%18.9%
Growth
Revenue growth (1 yr)8.2%9.8%
Revenue growth (5 yrs, per year)6.3%12.1%
EPS growth (5 yrs, per year)16.5%26.3%
Balance sheet and payouts
Net cash (cash minus debt)-$16.1B$400M
Dividend yield1.94%1.10%
Shareholder yield3.6%3.2%
Analysts
Upside to average target+4%+10%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: BDX TTM to September 30, 2026, RMD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Becton Dickinson & or Resmed?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Resmed scores 4.2 out of 5 and Becton Dickinson & 2.0; the table shows where each one is stronger.

Is Becton Dickinson & cheaper than Resmed?

On trailing earnings, Resmed trades at a P/E of 21.8 and Becton Dickinson & at 43.1, so Resmed is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Becton Dickinson & or Resmed?

Over five years Resmed grew revenue about 12.1% a year and Becton Dickinson & about 6.3% a year.

Which pays a higher dividend?

Becton Dickinson & yields 1.94% and Resmed 1.10%.

Full Becton Dickinson & analysis → Full Resmed analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.